The role of c-Jun N-terminal kinases 1/2 in transforming growth factor β1-induced expression of connective tissue growth factor and scar formation in the cornea

Journal of International Medical Research

Volumn 37, Issue 3, 2009, Pages 727-736

  Chang, Y ^a   Wu, Xinyi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

c Jun N terminal kinase; Connective tissue growth factor; Corneal cells; Gene expression; In vitro study; Transforming growth factor 1; Wound

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGEN TYPE 1; COLLAGEN TYPE 1ALPHA1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; COLLAGEN TYPE I, ALPHA 1 CHAIN; MITOGEN ACTIVATED PROTEIN KINASE 9; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA LESION; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR FORMATION; SIGNAL TRANSDUCTION; WOUND HEALING; CELL LINE; CELL MOTION; CORNEA; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SCAR;

ANTHRACENES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CICATRIX; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; CORNEA; ENZYME ACTIVATION; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHOSPHORYLATION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 70349254140     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700316     Document Type: Article

References (18)

1. Munoz B, West SK: Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol 2002; 86: 498-504. (Pubitemid 34454490)
2. Netto MV, Mohan RR, Ambrosio R, et al: Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea 2005; 24: 509-522.
3. Schnaper HW, Hayashida T, Hubchak SC, et al: TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284: F243-F252. (Pubitemid 36114687)
4. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999; 20: 189-206.
5. Frazier K, Williams S, Kothapalli D, et al: Stimulation of fibroblast cell growth, matrix production and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-411. (Pubitemid 26284351)
6. 1 and Smad signaling pathway in corneal wound healing. Chin Med J (Engl) 2006; 119: 57-62.
7. Igarashi A, Okochi H, Bradham DM, et al: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637-645. (Pubitemid 23183611)
8. Blalock TD, Yuan R, Lewin AS, et al: Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation. Exp Eye Res 2004; 78: 1127-1136. (Pubitemid 38510350)
9. 1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2003; 28: 754-761.
10. Ljubimov AV, Alba SA, Burgeson RE: Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res 1998; 67: 265-272.
11. Andrew L: TGFβ, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007; 74: 207-212.
12. 1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, Bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem 2007; 282: 7723-7732.
13. Leask A, Abraham DJ: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006; 119: 4803-4810. (Pubitemid 46017793)
14. Rosette C, Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996; 274: 1194-1197. (Pubitemid 26389285)
15. Kyriakis JM, Banerjee P, Nikolakaki E: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 69: 156-160. (Pubitemid 24153440)
16. Chuang SM, Wang IH, Yang JL, et al: Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 2000; 21: 1423-1432.
17. Gururajan M, Chui R, Karuppannan AK, et al: c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood 2005; 106: 1382-1391. (Pubitemid 41129605)
18. Barr RK, Boehm I, Attwood PV, et al: The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK. J Biol Chem 2004; 35: 3632-36338. (Pubitemid 39128970)